Abstract
The effect of ofloxacin on the microflora in saliva, gastric juice, and feces was evaluated in 24 patients undergoing gastric surgery. A single peroral dose of 400 mg ofloxacin was given to each patient 2–4 h before surgery. The concentrations of ofloxacin in serum, saliva, gastric juice, and gastric mucosa tissue were assayed. OnlyBranhamella cocci were affected in the saliva. In the gastric juice, both the aerobic and anaerobic flora were suppressed on the day of surgery, but increased in number afterwards. There was a significant correlation between gastric pH and the number of microorganisms isolated in the gastric juice on day 0. In faeces, the aerobic and part of the anaerobic flora were suppressed by the administration of ofloxacin. Ofloxacin was well tolerated by the patients. Four of 24 patients developed postoperative complications. Microorganisms isolated from wound sepsis and intraabdominal sepsis (three patients) wereStaphylococcus epidermidis, Staphylococcus aureus, hemolytic streptococci group A,Streptococcus sp. andEscherichia coli. All related infections occurred in patients with very low ofloxacin serum concentrations, probably due to impaired absorption. Oral antibiotic prophylaxis is not recommended in patients in whom impaired gastric emptying can be expected.
Similar content being viewed by others
References
Stone, H. H., Hooper, C. A., Kolb, L. B., Geheber, C. E. Dawkins, E. J. Antibiotic prophylaxis in gastric, biliary, and colonic surgery. Annals of Surgery 1976, 184: 443–452.
Keighley, M. R. B. Prevention of wound sepsis in gastro-intestinal surgery. British Journal of Surgery 1977, 64: 315–321.
Gatehouse, D., Dimock, F., Burdon, D. W., Alexander-Williams, J., Keighley, M. R. B. Prediction of wound sepsis following gastric operations. British Journal of Surgery 1978, 65: 551–554.
Muscroft, T. J., Deane, S. A., Youngs, D., Burdon, D. W., Keighley, M. R. B. The microflora of the post-operative stomach. British Journal of Surgery 1981, 68: 560–564.
Sjöstedt, S., Heimdahl, A., Kager, L., Nord, C. E. Microbial colonization of the oropharynx, esophagus and stomach in patients with gastric diseases. European Journal of Clinical Microbiology 1985, 4: 49–51.
Nord, C. E., Kager, L., Heimdahl, A. Impact of antimicrobial agents on the gastrointestinal microflora and the risk of infections. American Journal of Medicine 1984, 76: 99–105.
Monk, J. P., Campoli-Richards, D. M. Ofloxacin: A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs 1987, 33: 346–391.
Lockley, M. R., Wise, R., Dent, J. The pharmacokinetics and tissue penetration of ofloxacin. Journal of Antimicrobial Chemotherapy 1984, 14: 647–652.
Wise, R., Lister, D., McNulty, C. A. M., Griggs, D., Andrews, J. M. The comparative pharmacokinetics of five quinolones. Journal of Antimicrobial Chemotherapy 1986, 18: 71–81.
Heimdahl, A., Nord, C. E. Effect of phenoxymethylpenicillin and clindamycin on the oral, throat and faecal microflora of man. Scandinavian Journal of Infectious Disease 1979, 11: 233–242.
Lewis, R. T. Wound infections after gastroduodenal operations: A 10-year review. Canadian Journal of Surgery 1977, 20: 435–440.
Ischihara, N., Tachizawa, H., Tsumura, M., Une, T., Sato, K. Phase I study on DL-8280. Chemotherapy (Tokyo) 1984, 32: 118–149.
Pecquet, S., Andremont, A., Tancrede, C. Effect of oral ofloxacin on fecal bacteria in human volunteers. Antimicrobial Agents and Chemotherapy 1987, 31: 124–125.
Kern, W., Kurrle, E., Vanek, E. Ofloxacin for prevention of bacterial infections in granulocytopenic patients. Infection 1987, 15: 427–432.
Chida, T., Shibaoka, H., Ishizuka, I., Nakaya, R. The effect of DL-8280, a new antibacterial agent of pyridone-carboxylic acid derivative, on human fecal flora. Chemotherapy (Tokyo) 1984, 32: 109–117.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Edlund, C., Kager, L., Malmborg, A.S. et al. Effect of ofloxacin on oral and gastrointestinal microflora in patients undergoing gastric surgery. Eur. J. Clin. Microbiol. Infect. Dis. 7, 135–143 (1988). https://doi.org/10.1007/BF01963066
Issue Date:
DOI: https://doi.org/10.1007/BF01963066